We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02545868
Brief Title: A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

First Submitted : September 8, 2015
First Submitted that Met QC Criteria : September 8, 2015
First Posted : September 10, 2015 (Estimate)

Results First Submitted : February 13, 2018
Results First Submitted that Met QC Criteria : May 2, 2018
Results First Posted : June 6, 2018

Last Update Submitted that Met QC Criteria : April 4, 2022
Last Update Posted : April 28, 2022